In vitro and in vivo rationale for the triple combination of panobinostat (LBH589) and dexamethasone with either bortezomib or lenalidomide in multiple myeloma
収録刊行物
-
- Haematologica
-
Haematologica 95 (5), 794-803, 2009-11-30
Ferrata Storti Foundation (Haematologica)